TLR3, IFN-␤, IFN-regulating factors, proinflammatory cytokines, and class I major histocompatibility complex (MHC), whereas genes associated with thyroid hormonogenesis (sodium/iodide symporter, peroxidase, deiodinases) were suppressed. In accordance to these data, Poly(I:C) suppressed TSH-induced 125 I uptake and hormone synthesis dose dependently, accompanied by a decrease in the ratio of 125 I-T 3 / 125 I-T 4 released into the culture medium, whereas peptidoglycan, lipopolysaccharides, or unmethylated CpG DNA, ligands for TLR2, TLR4, and TLR9, respectively, had no significant effect. These inhibitory effects of Poly(I:C) were not blocked by a neutralizing antibody against TLR3 and an anti-IFN ␣/␤ receptor antibody. These in vitro findings suggest that when thyrocytes are infected with certain viruses, dsRNA formed intracellularly in thyrocytes may be a cause for thyroid dysfunction, leading to development of autoimmune thyroiditis.
(Endocrinology 148: 3226 -3235, 2007)
A LTHOUGH VIRAL INFECTION is thought to be associated with subacute thyroiditis and probably with autoimmune thyroid disease, possible changes in thyroid function during the prodromal period of infection or subclinical infection remain largely unknown (1, 2) . It was suggested that viral infection and/or tissue damage result in release of double-stranded DNA (dsDNA), which in turn enhances antigen presentation in the thyroid (3). Recently, it was shown that pathogen-associated molecular patterns (PAMPs) stimulate Toll-like receptors (TLRs) and activate innate immune responses by producing type I interferons (IFN) (4 -6) . Type I IFNs (both IFN-␤ and multiple IFN-␣ molecules) are the key cytokines produced after viral infection that mediate induction of both the innate immune response and subsequent development of adaptive immunity to viruses (4 -6) . Type I IFNs reversibly inhibit iodine incorporation and thyroid hormone release in human thyroid follicles (7) and confluent monolayers by inhibiting the thyroid peroxidase (TPO), sodium/iodide symporter (NIS), and thyroglobulin genes (8) . TLR activation by PAMPs is also associated with production of proinflammatory cytokines, such as IL-1, TNF-␣, and IL-6, which modulate thyroid hormonogenesis in vitro (9 -11) . A recent prospective study of hepatitis C virus-positive patients treated with IFN-␣ has suggested that both the innate and acquired immune system are involved in autoimmune thyroiditis (12) .
Among more than 10 members of the TLR family identified in mammals (5, 6) , TLR1, TLR2, TLR6, and TLR4 are involved in the recognition of bacteria, whereas TLR3, TLR7/ TLR8, and TLR9 are involved in the recognition of doublestranded RNA(dsRNA), single-stranded RNA (ssRNA), and unmethylated CpG DNA, respectively (6, 13, 14) . dsRNA can be generated during viral infection as a replication interme-diate for ssRNA viruses or as a by-product of symmetrical transcription in DNA viruses (15) . A synthetic analog of viral dsRNA, polyinosinic-polycytidylic acid [Poly(I:C)], is also recognized by TLR3, and has been used extensively to mimic viral infection (6) . TLR3 is expressed not only in immunocompetent cells, but also in various epithelial cells, such as human respiratory cells, intestinal cells, and rat thyroid-like cells (16 -18) . Very recently, it was demonstrated that dsRNA-mediated TLR3 activation is enhanced by CD14, a ligand for endotoxin and TLR3 (19) . Furthermore, dsRNA synthesized in the cytoplasm is recognized intracellularly by cytoplasmic helicase proteins, such as retinoic-acid-inducible protein-1 (RIG-1) and melanoma differentiation-associated gene 5 (MDA5) (5, 6, 20) .
Using suspension-cultured human thyroid follicles, which release de novo synthesized thyroid hormones into the culture medium in the presence of physiological concentrations of human TSH (21), we studied the effects of Poly(I:C) on TSHinduced thyroid function. Because stimulation of the type I IFN system activates a number of genes (5, 6), we studied the effects of Poly(I:C) on human thyrocytes using an oligo-DNA microarray in which the whole human genome can be analyzed in a single run (22) .
Materials and Methods Reagents
Lipopolysaccharide (LPS) from Salmonella Minnesota Re-595 was purchased from Sigma (St. Louis, MO). Poly(I:C) and CpG oligodeoxynucleotide were purchased from Hokkaido System Science (Hokkaido, Japan). Anti-IFN␣/␤ receptor antibody was obtained from PBL Biological Laboratories (Piscataway, NJ). Antihuman TLR3 monoclonal antibody (Anti-TLR3-Ab) was prepared as described previously (23) , and a lot containing the same neutralizing activity was used (23) .
Thyroid follicles in suspension culture
This study was approved by the Ethics Committee of Tokyo Women's Medical University. Informed consent was obtained from all patients with Graves' disease before subtotal thyroidectomy. Human thyroid follicles were cultured as reported previously (24) . In brief, thyroid tissue (15-30 g ) obtained by subtotal thyroidectomy from patients with Graves' disease was minced with scissors into small pieces (3 ϫ 3 ϫ 3 mm). The dissected thyroid tissue was digested with 0.3 mg/ml collagenase (type IV; Worthington Biochemical Corp., Lakewood, NJ) and 5 mg/ml dispase (Godo Shusei Co., Tokyo, Japan) in Hanks' balanced salt solution at 32 C for 30 min. The digested material was filtered through nylon mesh (80 mesh), and the undigested tissue fragments were processed in the same manner once more. The second filtrate containing thyroid follicles was centrifuged at 70 ϫ g for 5 min, and the pellet was washed three times with F-12/RPMI-1640 medium until the color of the pellet became white.
To investigate the effect of Poly(I:C) on gene expression, thyroid follicles were resuspended in F-12/RPMI-1640 medium containing NaI (10 Ϫ8 m) and 0.5% fetal calf serum (about 2000 -3000 thyroid follicles/ml), and about 15 ml were added to 10-cm culture dishes, the bottom of which had been coated with agarose (7, 8, 10) . After culturing for 4 -5 d, bovine TSH (bTSH) was added to a final concentration of 30 U/ml, and cultured for additional 1 d, then Poly(I:C) was added to a final concentration of 25 g/ml. After an additional 6 or 24 h culture, total RNA was prepared from thyroid follicles treated with or without Poly(I:C).
RNA extraction
Total RNA was extracted from thyroid follicles using the RNeasy Minikit (QIAGEN, Tokyo, Japan) according to the manufacturer's suggested protocol (22, 25) . Concentration and purity were determined using a GeneQuant spectrophotometer (Amersham Pharmacia Biotech, Cambridge, UK). The quality of the RNA was checked by electrophoresis of 1-g samples in 1.0% formaldehyde agarose gel, followed by staining with ethidium bromide. The 28S and 18S rRNA bands were examined on a UV transilluminator. No significant degradation was observed in any of the RNA samples.
Oligo-DNA microarray
After the RNA had been extracted, oligo-DNA microarray was performed as described previously (22) . In brief, RNA was converted to cDNA using a Human cDNA System I Direct Kit (NEN Life Science Products, Boston, MA). cDNA obtained from thyroid follicles cultured in the control and treated media was labeled with Cy3 (green, control) and Cy5 [red, Poly(I:C)], respectively, and the expression levels of 41000 gene spots were analyzed using cDNA microarray (Whole Human Genome Oligo Microarray Kit, Product No. G4112A; Agilent Technologies, Palo Alto, CA).
Laser detection of the Cy3 and Cy5 signals on the microarray was performed with a nonconfocal laser leader, Gene PX 4000A (Axon Instruments, Union, CA). Fluorescence signal intensities and the Cy5/Cy3 ratios for each of the 41000 oligo-DNAs were analyzed using the Gene PixPro 30 software package (Axon Instruments).
Real-time RT-PCR
Total RNA (250 ng) was reverse-transcribed in a total reaction volume of 100 l using a high-capacity cDNA archive kit (Applied Biosystems, Foster City, CA) in accordance with the manufacturer's instructions. cDNA was synthesized using a thermal cycler (program temperature control system PC-7000; ASTEK, Fukuoka, Japan) by incubation at 25 C for 10 min, and at 37 C for 120 min. Single-stranded cDNA products were then analyzed by real-time PCR using the TaqMan Gene Expression Assay in accordance with the manufacturer's instructions (Applied Biosystems). Single-stranded cDNA products were analyzed using an ABI PRISM 7700 Sequence Detector (Applied Biosystems). Twelve assays were performed: TLR-2 (Hs00152932-m1), TLR-3 (Hs00152933-m1), TLR-4 (Hs00152937-m1), TLR-9 (Hs00152973-m1), IFN-␣ (Hs00256882-s1), IFN-␤ (Hs00277188-s1), RIG-1 (Hs00204833-m1), MDA5 (Hs00223420-m1), thyroglobulin (Hs 00174974-m1), peroxidase (Hs00174927-m1), type I deiodinase (Hs00174944-m1), and type II deiodinase (Hs00255341-m1), using 18S rRNA (Hs99999901-s1) as a control. The PCR thermal cycle conditions were set at 50 C for 2 min and 95 C for 10 min, followed by 40 cycles of 95 C for 15 sec and 60 C for 1 min. In each case, triplicate threshold cycle (Ct) values were obtained and averaged, and the expression levels were then evaluated using a relative quantification method. The fold change in target genes was normalized to the 18S rRNA (reference gene) and compared with the control (calibrator) sample, using the formula: Fold change ϭ 2 Ϫ⌬⌬Ct , where ⌬⌬Ct ϭ (Ct-target Ϫ Ct-reference)sample-n Ϫ (Ct-target Ϫ Ct-reference)calibrator-sample. Sample-n corresponds to any sample for the target gene normalized to the reference gene, and calibrator-sample represents the expression level (1ϫ) of the target gene normalized to the reference gene.
Effects of PAMPs on TSH-induced thyroid function
To investigate the effects of PAMPs on TSH-induced thyroid function, follicles were resuspended in the supplemented F-12/RPMI-1640 medium, which was a 1:1 mixture of F-12 and RPMI-1640 medium supplemented with 2 mg/ml BSA, bovine insulin (5 g/ml), hydrocortisone (10 Ϫ8 m), bovine transferrin (5 g/ml) and NaI (10 Ϫ8 m). One milliliter of follicular suspension (containing 200 -300 follicles) was cultured in the presence of 30 U/ml TSH in a humidified atmosphere of 5% CO 2 and 95% air at 37 C in 24 multiwell dishes the bottom of which had been coated with agarose (7, 8, 10) .
After 5 d of culture, the culture medium was changed to supplemented F-12/RPMI-1640 medium containing 30 U/ml bTSH and various concentrations of LPS, peptidoglycans, Poly(I:C), PolyC, or Poly(dI: dC), and cultured for 1 h. Then, 1.5-2.0 ϫ 10 4 cpm 125 I was added. After an additional 3 d of culture, the medium and the thyroid follicles were transferred to glass tubes each with a sharp-pointed bottom (12 ϫ 75 mm, made to order by Sugiyama-gen, Tokyo, Japan) and centrifuged at 2000 ϫ g for 10 min. The conditioned medium was transferred to another standard-type glass tube, and then 100 l of fetal bovine serum and 200 l of 50% trichloroacetic acid (TCA) were added. After a through mixing, the tubes were centrifuged, and the TCA-precipitates were washed once with 5% TCA. To measure iodide incorporation into follicles, the tubes containing thyroid follicles were gently washed with 1 ml Hanks' solution. The radioactivity in the pellets (organic 125 I released) and the follicles ( 125 I incorporated) was counted in a ␥-spectrometer (Aloka, Tokyo, Japan). All assays were performed in triplicate or quadruplicate.
To study whether it is possible to prevent dsRNA-induced thyroid dysfunction using Anti-TLR3-Ab, thyroid follicles were preincubated with the antibody at 5 and 20 g/ml as reported elsewhere (23) . After a 1-h incubation, dsRNA was added at a final concentration of 1 g/ml, and then 125 I was added. After an additional 3 d of culture, 125 I incorporated into the thyroid follicles and organic 125 I secreted into the culture medium were counted.
Analysis of 125 I-labeled metabolites by thin-layer chromatography
After thyroid follicles had been cultured in the medium containing various concentrations of Poly(I:C) and bTSH (50 U/ml) for 3 d, they and the conditioned medium were stored at Ϫ20 C. The thyroid follicles were then treated with proteinase A at room temperature overnight. After lyophilization of the samples, 125 I-metabolites in the thyroid follicles and conditioned medium were extracted with butanol, and analyzed by thin-layer chromatography as described previously (26) .
Determination of IFN-␣ and -␤ concentrations in the conditioned medium
Culture media were centrifuged to remove cell debris, and the supernatants were stored at Ϫ80 C until assay. The levels of IFNs secreted into the culture medium were determined with ELISA kits for human IFN-␣ (Funakoshi TBL, Tokyo, Japan) and human IFN-␤ (Torei, Tokyo, Japan) in accordance to the manufacturers' protocols. The sensitivities for IFN-␣ and -␤ were less than 12.5 pg/ml and 2.5 pg/ml, respectively.
Immunohistochemistry
Graves' thyroid tissues were fixed in 10% neutral buffered formalin for 24 h, then embedded in paraffin as a routine procedure. Modified antigen retrieval method (27) was used for the immunohistochemical visualization of TLR3. Briefly, sections were placed in a plastic Coplin jar filled with 0.001 n NaOH and heated for 5 min at 120 C in an autoclave. Sections were then exposed to a 3% H 2 O 2 to inactivate endogenous peroxidase and incubated at 4 C overnight with 1:100 dilution of purified monoclonal antihuman TLR3 antibody (Anti-TLR3-Ab), as described previously (23) . Labeled Streptavidin-Biotin method (LSABϩ System HRP kit; Dako, Glostrup, Denmark) was used according to the manufacture's protocol. 3,3Ј-Diaminobenzidine tetrahydrochloride was used to detect peroxidase activity. Sections were lightly counterstained with hematoxylin for 10 sec to visualize nuclei.
Statistical analysis
Differences between groups were analyzed by ANOVA with pairwise comparison by Sheffe's method, using Statview (Abacus Concepts, Berkley, CA). Statistical significance was accepted at P Ͻ 0.05.
Results

Expression of mRNA for pattern recognition receptors in human thyroid follicles cultured in the presence or absence of TSH
In accordance with a previous report (28) , human thyroid follicles expressed significant levels of TLR mRNAs. Because human thyrocytes expressed TSH receptor (TSHR) [NM_000369] constitutively and its expression was not modulated by TSH (22) , and because all TLRs were expressed to the same extent as TSHR, the levels of TLR expression were compared with those of TSHR. As shown in Table 1 , TLR-4, -8, and -10 were hardly expressed, whereas TLR-1, -2, -3, and -6 were expressed almost equivalently in the thyroid follicles. RIG-I, MDA5, and CD14, other molecules responsible for the recognition of dsRNA, were expressed at levels nearly double that of TSHR ( Table 1 ). The expression levels of these molecules were not significantly modulated by TSH (data not shown). Thyroid follicles were cultured with bTSH for several days, and then total RNA was extracted, and subjected to oligo-DNA microarray. The expression levels were compared with those of TSHR, and expressed as fold-changes. Data are means Ϯ SD of 11 experiments.
FIG. 1. Oligo-DNA microarray analysis of Poly(I:C) effect on mRNA expression in cultured human thyroid follicles. Human thyroid follicles were precultured in the absence of bTSH for 4 d and in the presence of bTSH (30 U/ml) for 1 d, and then Poly(I:C) was added to a final concentration of 25 g/ml. After 6-h incubation, total RNA was extracted and oligo-DNA microarray was performed as described in Materials and Methods. Representative data from three experiments are shown. CXCL, Chemokine (C-X-C) ligand; DIO, deiodinase; HLA, human leukocyte antigen; IFIT, IFN-induced protein with tetratricopeptide repeat; IRF, IFN regulatory factor; SLC26A4, pendrin; VEGF, vascular endothelial growth factor.
Analysis of genes regulated by dsRNA in the thyroid
DNA microarray analysis was carried out to compare mRNA expression profiles 6 h after Poly(I:C) stimulation. Consistent with our previous study (22) , expression levels of thyroglobulin and peroxidase mRNA were most abundant (Fig. 1) . Among 41,000 gene spots tested in the array analysis, more than 900 and 100 genes were up-regulated more than 2-and 10-fold by dsRNA, respectively, whereas more than 200 genes were down-regulated to less than one half. Similar results were obtained in all three experiments. The enhanced genes included various IFN-responsive genes, cytokines, and chemokines (Table 2) . Furthermore, expression of a number of MHC class I antigens more than doubled, whereas that of MHC class II antigens was unchanged (Table 3) .
In contrast to type I IFN-regulated genes, the dsRNA analog decreased the expression levels of mRNA for TSHR, NIS, pendrin, sialyltransferase, and type I and II deiodinases after 6 h (Table 4) . These inhibitory effects were generally more potent at 24-h than at 6-h incubation with Poly(I:C) (data not shown). Although the mRNA expression levels of thyroglobulin and peroxidase were not decreased by 6 h (Table 4) , real-time PCR analysis revealed that both mRNA expression levels gradually decreased to less than 50% after 48 h (Fig. 2A) . The expression level of mRNA for type I and II deiodinases was also decreased to 60% at 6 h and to less than 50% by 48 h, respectively (Fig. 2B) . Chemokine (C-X-C motif) ligand 9 (CXCL9), ͓NM_002416͔
Chemokine (C-C motif) ligand 3 (CCL3), ͓NM_002983͔ a Although mRNA expression levels of Tg and TPO did not decrease after 6-h incubation, both expression levels decreased to less than half after 48 h as described in Fig. 2 .
dsRNA inhibits TSH-induced thyroid function
As reported previously (11, 21, 24) , TSH stimulates 125 I incorporation into cultured human thyroid follicles and release of de novo synthesized thyroid hormones ( 125 I-T 4 and 125 I-T 3 ) into the culture medium. When Poly(I:C), a synthetic homolog of viral dsRNA, was added to the culture medium, TSH-induced iodide incorporation and hormone secretion were dose-dependently and completely suppressed (Fig. 3B) . Consistent with these findings, analysis of 125 I-metabolites by thin-layer chromatography revealed that TSH stimulated the synthesis of 125 I-T 3 and 125 I-T 4 , and that this was inhibited dose dependently by Poly(I:C) in thyroid follicles (Fig. 4,  lower panel) . Furthermore, Poly(I:C) dose dependently decreased the ratio of 125 I-T 3 / 125 I-T 4 released into the culture medium (Fig. 4, upper panel) .
In contrast to Poly(I:C), peptidoglycan, a major cell wall component of gram-positive bacteria that is recognized by TLR2, did not affect TSH-induced thyroid function (Fig. 3A) . Although LPS, a major component of gram-negative bacteria that is recognized by TLR4, is reported to increase thyroglobulin gene expression in rat thyroid FRTL-5 cells (29), it had no significant effect on TSH-induced hormone secretion in human thyroid follicles (Fig. 3C) .
To elucidate whether the observed effect was specific for Poly(I:C), we tested the effect of other nucleic acids, i.e. ss-RNA and dsDNA, on follicular function. Addition of ssRNA [Poly(C)] and dsDNA [Poly(dI:dC)] to the culture medium of human thyroid follicles had no significant effect on 125 I uptake or thyroid hormone secretion (Fig. 5) .
Effects of anti-TLR3-monoclonal antibody on TSH-induced thyroid function
In fibroblasts, TLR3 is expressed on the cell surface, and the effect of dsRNA is inhibited by a neutralizing monoclonal antibody against TLR3 (23) . In monocyte-derived immature dendritic cells, however, TLR3 resides within the cells and the effect of dsRNA is not blocked by the same antibody (30) . To investigate the localization of TLR3 in the thyroid, we first preincubated the cultured thyroid follicles with anti-TLR3 monoclonal antibody at a concentration that inhibited the effect of dsRNA in human fibroblasts (23) . As shown in Table  5 , anti-TLR3 antibody did not block dsRNA-induced suppression of iodide uptake or thyroid hormone secretion.
To confirm the expression of TLR3 protein in human thyroid follicles, formalin-fixed, paraffin-embedded thyroid tissues obtained from eight patients with Graves' disease by subtotal thyroidectomy were subjected to immunohistochemistry with antigen retrieval method. In all the Graves' thyroid, TLR3 was demonstrated in follicular epithelium with various staining intensity (Fig. 6, A-E, G, and H) . There was a tendency that staining was stronger in the epithelium near lymphocyte infiltration (Fig. 6E) . It is worth noting that antigen retrieval method was essential to visualize TLR3; no staining was demonstrated when this step was skipped (Fig.   6F ). Higher magnification clearly indicates granular staining of TLR3 within cytoplasm of thyrocyte (Fig. 6, G and H) .
Poly(I:C) acutely stimulates type I IFN-signaling pathway
Time course studies by real-time PCR analyses revealed that dsRNA acutely increased the expression of IFN-␤ mRNA more than 100-fold within 2 h after its addition to the culture medium (Fig. 7A) . The level of mRNA decreased 50-fold by 6 h, and then decreased gradually almost to the control level by 72 h. Consistent with these data, Poly(I:C) dose dependently increased the concentration of IFN-␤ in the first 12 h of culture (Fig. 7B) . In contrast, IFN-␣ concentration was below the detectable concentration (Ͻ12.5 pg/ml) in the conditioned medium, although the level of IFN-␣ mRNA was increased several fold by Poly(I:C) (Fig. 7A) .
To investigate whether IFNs secreted into the medium inhibited TSH-induced thyroid function, effects of anti-IFN-␣/␤ receptor antibody on TSH-induced thyroid function were studied. As reported previously (7), IFN-␤ inhibited TSH-stimulated thyroid function at 2000 U/ml. Although this inhibitory effect was partially reversed by anti-IFN-␣/␤ receptor antibody (Table 6 , part I), the antibody did not modulate Poly(I:C)-induced inhibition of thyroid function (Table 6 , part II).
Among 10 TLRs, the expression of TLR3 mRNA was increased more than 10-fold at 6 h and then decreased gradually (Fig. 8) . Expression of TLR2, TLR4, and TLR9 was not significantly affected by addition of dsRNA. Furthermore, RIG-1 and MDA5 were also increased more than 100-and 50-fold at 6 h, respectively, and then decreased gradually to several fold by 48 h (Fig. 9) . Through the TLR3 and RIG-1/ MDA signaling pathways, a number of IFN-regulatory proteins were increased, leading to stimulation of antiviral mechanisms such as 2Ј,5Ј-oligoadenylate synthetases and IFN-inducible double-stranded RNA-dependent-protein kinase (PRKR) ( Table 2 ), suggesting that once thyrocytes were invaded by viruses, dsRNA will be produced intracellularly, and that the dsRNA will promptly activate native immunity to protect the host from viral infection (31) .
There was a very good correlation between data obtained 
Discussion
Cellular production of type I IFNs occurs after viral infection. It is now at least partly clear that dsRNA, which is produced by most viruses at some point during their replication cycle, triggers such a response (6) . To study the effect of dsRNA on thyroid function, we have used suspension culture of human thyroid follicles in which thyroid hormones are synthesized de novo and secreted into the culture medium in the presence of a physiological concentration of human TSH (21) . We have demonstrated that addition of a dsRNA analog to the culture medium without transfection by lipofectamine dose dependently and almost completely suppressed TSH-induced iodide uptake and thyroid hormone secretion, accompanied with decreased mRNA expression of TSHR, NIS, thyroglobulin, peroxidase, and type I and II deiodinases. The effect was specific for RNA, but not DNA, and also specific for the double-stranded structure.
The present in vitro findings support previous reports on the modulation of thyroid function after viral infection in the thyroid. Thus, lymphocytic choriomeningitis virus can persistently infect thyroid epithelial cells and perturb thyroid hormone production (32) . Similar findings have been reported in mice neonatally infected with lymphocytic choriomeningitis virus, which persists in the thyroid gland without necrosis or inflammation, and reduces the expression level of thyroglobulin mRNA and circulating thyroid hormones (33) . When 10-d-old chicken embryos were infected with an avian leukosis virus, RAV-7, hypothyroidism developed within 3 wk after hatching, accompanied by extensive infiltration of lymphoblastoid cells by 7 d after hatching (34) .
We have also shown that dsRNA increases the expression level of MHC class I. This is consistent with previous in vitro findings that reovirus enhances the expression of MHC class I molecules in cultured human thyroid follicular cells through induction of type 1 IFN (35) . Furthermore, viruses are also reported to induce class II MHC expression in thyroid cells (36, 37) . Although the precise mechanism of these effects is unknown, it would allow nonprofessional antigenpresenting cells such as thyrocytes to present self or foreign antigens to immune cells. As a result, autoimmune thyroiditis may occur after viral infection, as has been reported in mice infected with reovirus (38) . In our in vitro study, however, the effect of dsRNA on MHC gene expression was restricted to class I antigens, because few immunocompetent cells were present in our experimental model (39) , suggesting that addition of dsRNA to the culture medium was not enough to induce MHC class II expression. The underlying molecular mechanism by which dsRNA inhibits 125 I incorporation and thyroid hormonogenesis remains to be elucidated. One of the likely explanations is that IFN-␤ produced by dsRNA stimulation is secreted to the outside of the cell, where it exerted inhibitory effects in an autocrine or paracrine manner through type I IFN receptors expressed on the plasma membrane. However, this was unlikely under the present experimental conditions, because anti-IFN-␣/␤ receptor neutralizing antibody did not block dsRNA-induced thyroid dysfunction (Table 6) . Recently, Lee et al. (19) demonstrated that dsRNA binds to CD14 expressed on the plasma membrane and that dsRNA/CD14 complex activates TLR3. Furthermore, dsRNA activates nuclear factor-B or MAPK pathways independent of the signaling pathway through IFN-␣/␤ receptor (5, 6) . Because thyrocytes treated with dsRNA show increased levels of various cytokines, and chemokines in addition to IFNs, which inhibit thyroid function (9 -11), these might be responsible for the dsRNA-initiated inhibitory action in the thyroid.
Very recently, Harii et al. (18) , using monolayer cultures of rat thyroid FRTL-5 cells, observed that dsRNA activates various signaling molecules such as nuclear factor-B, MAPK, IFN regulatory factor-3, and IFN-␤. They also demonstrated that transfection of dsRNA, infection with influenza A virus, or incubation with IFN-␤, but not incubation with dsRNA or IFN␥, enhanced the expression of TLR3, and suggested that thyrocytes express functional TLR3. In contrast to human fibroblasts, in which TLR3 is expressed on the cell surface and an anti-TLR3 monoclonal antibody inhibits dsRNA-induced IFN-␤ production (23), pretreatment of thyroid follicles with the same antibody did not block dsRNA-induced suppression of thyroid function, suggesting that TLR3 was predominantly located intracellularly in the thyroid follicles, probably in endosome-like vesicles, rather than in the plasma membrane, as reported in immature human dendritic cells and human alveolar and bronchial epithelial cells (16, 30) . Our immunohistochemical studies also provided support for the intracellular expression of TLR3 in human thyroid follicles from Graves' disease patients (Fig. 6) . Although Harii et al. (18) demonstrated TLR3 expression in thyrocytes obtained from patients with Hashimoto's thyroiditis, but not in those with Graves' disease, our present findings suggest that TLR3 is present even in the Graves' thyroid. The present data seem to be quite reasonable because we have detected TLR3 mRNA from Graves' thyroid using DNA microarray and real time PCR. Also, Harii et al. (18) actually demonstrated TLR3 mRNA in normal mouse thyroid, rat thyroid FRTL-5 cells, and NPA human papillary thyroid cells. Our results suggest that the efficiency of antigen-retrieval methods and the sensitivity of immunohistochemistry significantly affect the staining.
It is well known that antiviral antibodies against single-
Real-time PCR analysis of Poly(I:C) effect on expression levels of TLR-2, -3, -4, and -9 mRNA. Human thyroid follicles were precultured in the absence of bTSH for 4 d and in the presence of bTSH (30 U/ml) for 1 d, and then Poly(I:C) was added to a final concentration of 25 g/ml. After 0.5-, 2-, 6-, and 24-h incubation, total RNA was extracted and real-time PCR was performed as described in Materials and Methods. Data are mean Ϯ SD of triplicate determinations. Where error bars are not seen, SD is less than the triangles. E-E, TLR2; F-F, TLR3; OE-OE, TLR4; ‚-‚, TLR9. Representative data from two experiments are shown.
FIG. 6.
Immunohistochemistry of thyroid gland with anti-TLR3-antibody. Thyroid tissue, obtained from patients with Graves' disease at subtotal thyroidectomy, was stained with anti-TLR3 monoclonal antibody using antigen retrieval method as described in Materials and Methods. Five representative Graves' thyroids were shown in A-E. Immunostaining without antigen retrieval method gave no staining (F). G and H are high magnification of follicular epithelium stained with anti-TLR3. Original magnification: A-F, ϫ100; G and H, ϫ1000.
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FIG. 7. Real-time PCR analysis of Poly(I:C) effect on IFN-␣ and IFN-␤ mRNA expression levels and IFN-␤ concentration in the conditioned medium. Human thyroid follicles were precultured in the absence of bTSH for 4 d and in the presence of bTSH (30 U/ml) for 1 d, and then Poly(I:C) was added to a final concentration of 25 g/ml. After 1-, 2-, 6-, 24-, 48-, and 72-h incubation, total RNA was extracted and real-time PCR was performed as described in Materials and Methods (A). F-F, IFN-␤; E-E, IFN-␣. Representative data from two experiments are shown. IFN-␤ concentration in the conditioned medium was measured using ELISA with an assay sensitivity of less than 2.5 pg/ml. Data are mean Ϯ SD of triplicate cultures (A and B).
Where error bars are not seen, SD is less than the circles. IFN-␣ concentration was below the detection limit of the assay (Ͻ12.5 pg/ml) (data not shown).
stranded RNA viruses (influenza, coxsackie, mumps, and echo viruses) as well as dsDNA virus (adenovirus) transiently increase in patients with de Quervain subactue thyroiditis (40) . There is a general consensus that once these viruses enter thyrocytes through various pathways (41), dsRNA will be produced. Thus, without interacting with the TLR3-mediated signaling pathway (5, 6), the dsRNA can interact with RIG-1 and MDA5 in the cytoplasm, and these complexes also stimulate the type I IFN system (5, 6). Our in vitro data are compatible with clinical observations that no particular, pathognomonic viruses have been isolated from patients with subacute thyroiditis (42) . Furthermore, our data suggest that in the prodromal period of subacute thyroiditis, serum levels of T 4 and, to a greater extent, T 3 would be transiently decreased. The present findings are compatible with some clinical reports describing that a euthyroid patient with mumps, who developed thyroid swelling and a diffusely reduced uptake in a thyroid scan (43) . However, in general, serum levels of thyroid hormones are not measured in the prodromal period in patients with subacute thyroiditis, but are routinely measured during the thyrotoxic period when thyroid follicles have been extensively destroyed. Therefore, any transient decrease in serum thyroid hormone levels during the prodromal period, or subclinical viral infections, would be obscured.
In summary, using human thyroid follicles de novo synthesizing and releasing thyroid hormones in the presence of physiological TSH concentration, we have shown that TLR signaling via dsRNA [Poly(I:C)] results in the production of type I IFN and inflammatory cytokines, leading to establishment of antiviral immunity, accompanied by thyroid dysfunction. These in vitro findings may be associated, at least in part, with development of thyroid dysfunction and would be related to the development of autoimmune thyroid disorders.
